102 related articles for article (PubMed ID: 2338642)
1. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
Zobrist RH; Mecca TE
J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
4. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
Murata S; Kikkawa K; Yabana H; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
[TBL] [Abstract][Full Text] [Related]
8. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of L-type Ca2+ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 2003 Apr; 466(1-2):63-71. PubMed ID: 12679142
[TBL] [Abstract][Full Text] [Related]
9. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
Kikkawa K; Murata S; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyproheptadine on [3H]-d-cis-diltiazem binding sites in cardiac sarcolemmal membranes of rats.
Xin HB; Zhang BH; Liu YW
Yao Xue Xue Bao; 1994; 29(9):641-6. PubMed ID: 7900533
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
Balwierczak JL; Johnson CL; Schwartz A
Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
[TBL] [Abstract][Full Text] [Related]
13. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
Bellemann P; Ferry D; Lübbecke F; Glossman H
Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of a novel 1,5-benzothiazepine calcium antagonist.
Shiga H; Miyake S; Ideka M; Ito Y; Yanagisawa H; Koike H
Arzneimittelforschung; 1992 May; 42(5):617-21. PubMed ID: 1530673
[TBL] [Abstract][Full Text] [Related]
15. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
16. Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.
Hering S; Savchenko A; Strübing C; Lakitsch M; Striessnig J
Mol Pharmacol; 1993 May; 43(5):820-6. PubMed ID: 8388993
[TBL] [Abstract][Full Text] [Related]
17. The unique binding properties of amlodipine: a long-acting calcium antagonist.
Nayler WG; Gu XH
J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
[TBL] [Abstract][Full Text] [Related]
18. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
19. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
20. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
Ishii A; Toyama J
J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
